138 related articles for article (PubMed ID: 31903696)
1. UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2.
Wang H; Su H; Tan Y
Cell Biol Int; 2020 Apr; 44(4):1028-1036. PubMed ID: 31903696
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
Fu J; Zhang Y; Wang M; Hu J; Fang Y
J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661
[TBL] [Abstract][Full Text] [Related]
3. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
Tan SF; Ni JX; Xiong H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
Chen XJ; An N
J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PITPNA-AS1 regulates UNC5B expression in papillary thyroid cancer via sponging miR-129-5p.
Mei S; Zong H; Zhou H
Int J Biol Markers; 2021 Mar; 36(1):10-19. PubMed ID: 33706585
[TBL] [Abstract][Full Text] [Related]
6. EZH2-mediated lncRNA ABHD11-AS1 promoter regulates the progression of ovarian cancer by targeting miR-133a-3p.
Zhang W; Huang X; Shi J
Anticancer Drugs; 2021 Mar; 32(3):269-277. PubMed ID: 33491971
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression.
Cai C; Peng X; Zhang Y
Bioengineered; 2021 Dec; 12(1):7007-7019. PubMed ID: 34551671
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
[TBL] [Abstract][Full Text] [Related]
9. Silencing UNC5B antisense lncRNA 1 represses growth and metastasis of human Colon cancer cells via raising miR-622.
Zhang Y; Li Z; Lan Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):60-67. PubMed ID: 31852293
[No Abstract] [Full Text] [Related]
10. Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme.
Song Y; Chen B; Jiao H; Yi L
BMC Med Genomics; 2024 Apr; 17(1):83. PubMed ID: 38594690
[TBL] [Abstract][Full Text] [Related]
11. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
12. The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2.
Xue W; Wang F; Han P; Liu Y; Zhang B; Gu X; Wang Y; Li M; Zhao Y; Cui B
Aging (Albany NY); 2020 Oct; 12(20):20396-20412. PubMed ID: 33109776
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
Bai Y; Li S
J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
[TBL] [Abstract][Full Text] [Related]
14. MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo.
Zhang Y; Liu F; Zheng J; Jiang K; Ai H; Liu L; Mao D
Exp Cell Res; 2024 Feb; 435(1):113913. PubMed ID: 38199479
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
16. lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.
Zeng XY; Jiang XY; Yong JH; Xie H; Yuan J; Zeng D; Dou YY; Xiao SS
Cancer Med; 2019 Nov; 8(16):7074-7085. PubMed ID: 31568657
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
Zhao X; Cheng Z; Wang J
Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
[TBL] [Abstract][Full Text] [Related]
20. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]